- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02291315
Calcium Absorption in Postmenopausal Thai Women
November 12, 2014 updated by: Cornell University
Calcium Bioavailability of Cassia Leaves in Post-Menopausal Women
Adequate calcium absorption is essential for reducing one's risk of developing osteoporosis.
However, postmenopausal Thai women consume diets which are habitually low in calcium due to lactose intolerance and dietary patterns which typically do not include milk-based products.
The primary goal of this study is to measure the fractional calcium absorption from milk and a commonly ingested green leafy vegetable (cassia) in postmenopausal Thai women with habitually low calcium intakes.
The secondary objective is to determine associations between calcium absorption and biomarkers which impact vitamin D status and bone metabolism.
Study Overview
Status
Completed
Conditions
Detailed Description
Postmenopausal Thai women (n=22) will be recruited from the community surrounding Bangkok and Nakhon Pathon, Thailand.
They will be invited to participate in an isotope study comparing the fractional calcium absorption from milk and cassia.
Upon arrival, a fasting blood sample will be drawn on the morning of the absorption study to analyze serum markers of vitamin D and bone metabolism (25-hydroxy vitamin D [25OHD], parathyroid hormone [PTH], and beta-crossLaps) and to determine their impact on calcium absorption.
Following this blood draw, women will receive a stable calcium isotope (42Ca) intravenously.
Then for breakfast and lunch respectively, the women will be randomly assigned to orally ingest a stable calcium isotope from either the milk (44Ca) or cassia (43Ca) test meals.
On day two, women will receive a breakfast, snack, and lunch meal.
Urine samples will be collected over the entire 28 hour period and the 24-hr urine collection will be used to measure urinary calcium concentration and to calculate fractional calcium absorption.
Study Type
Observational
Enrollment (Actual)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Ithaca, New York, United States, 14853
- Human Metabolic Research Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
53 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Post-menopausal Thai women
Description
Inclusion Criteria:
- Healthy
- At least 3 years postmenopausal
Exclusion Criteria:
- Diagnosed gastrointestinal or metabolic diseases known to interfere with calcium absorption and metabolism
- Women taking medications (including thiazide diuretics, hormonal replacement therapy, etc.) within two months prior to the study
- Women taking dietary supplements within two months prior to the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Test meal ingestion
On the morning of the absorption study, fasted women received 2 mg of 42Ca intravenously (in 5 ml of isotonic saline) over 5 minutes before being randomly assigned to receive either the milk or cassia meal first for breakfast and the milk or cassia meal second for lunch.
The milk meal consisted of approximately 100 mg of fresh ultrahigh temperature (UHT) milk to which 2 mg of 44Ca was added and allowed to equilibrate for 12 h prior to ingestion and the cassia meal consisted of 142 g of cooked cassia to which 1 mg of 43Ca was extrinsically added.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fractional calcium absorption
Time Frame: 24 hours after the ingestion of the second test meal
|
Urine samples will be collected over s 28 hour period post-dosing with collection ending 24 hours after the ingestion of the second test meal.
|
24 hours after the ingestion of the second test meal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The concentration of 25-hydroxy vitamin D (25OHD) in serum
Time Frame: Upon entry to the study, a 10 mL blood sample will be collected in a less than 2 hour time period.
|
A fasting 10 mL blood sample will be collected upon entry into the study and used for determining the concentration of 25OHD in serum.
|
Upon entry to the study, a 10 mL blood sample will be collected in a less than 2 hour time period.
|
The concentration of parathyroid hormone (PTH) in serum
Time Frame: Upon entry to the study, a 10 mL blood sample will be collected in a less than 2 hour time period.
|
A fasting 10 mL blood sample will be collected upon entry into the study and used for determining the concentration of PTH in serum.
|
Upon entry to the study, a 10 mL blood sample will be collected in a less than 2 hour time period.
|
The concentration of beta-crossLaps in serum
Time Frame: Upon entry to the study, a 10 mL blood sample will be collected in a less than 2 hour time period.
|
A fasting 10 mL blood sample will be collected upon entry into the study and used for determining the concentration of beta-crossLaps in serum.
|
Upon entry to the study, a 10 mL blood sample will be collected in a less than 2 hour time period.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Prapaisri P. Sirichakwal, PhD, Mahidol University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2007
Primary Completion (Actual)
September 1, 2007
Study Completion (Actual)
September 1, 2007
Study Registration Dates
First Submitted
November 10, 2014
First Submitted That Met QC Criteria
November 12, 2014
First Posted (Estimate)
November 14, 2014
Study Record Updates
Last Update Posted (Estimate)
November 14, 2014
Last Update Submitted That Met QC Criteria
November 12, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB #: MU 2007-145
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fractional Calcium Absorption
-
Swiss Federal Institute of TechnologyUniversity of ZurichCompleted
-
General Committee of Teaching Hospitals and Institutes...Not yet recruitingCalcium Citrate Absorption | Calcium Carbonate AbsorptionEgypt
-
UCSF Benioff Children's Hospital OaklandCompletedFractional Zinc AbsorptionUnited States
-
KU LeuvenNot yet recruitingIron Absorption | Zinc Absorption
-
University of California, DavisNot yet recruitingIron Absorption | Zinc AbsorptionUnited States
-
Azienda Ospedaliera Città della Salute e della...CompletedFractional Flow Reserve, MyocardialItaly
-
Malaysia Palm Oil BoardUniversity of MalayaCompleted
-
Bispebjerg HospitalCompletedPhotodynamic Therapy | Ablative Fractional LaserDenmark
-
University of PatrasCompleted
-
King's College LondonCompletedAbsorption; ChemicalsUnited Kingdom